DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia
Abstract Background Downstream of tyrosine kinase 6 (DOK6), which is specifically expressed in the nervous system, was previously recognized as an adapter only in neurite outgrowth. Recent studies also demonstrated the potential role of DOK6 in solid tumors such as gastric cancer and breast cancer....
Gorde:
| Egile Nagusiak: | , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wiley
2019-10-01
|
| Saila: | Cancer Medicine |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1002/cam4.2540 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|